“Tell me how you feel?” The yin and yang of symptoms in asthma
DAY 2
Chaired By: Dr Jane McDowell (Belfast), Professor Thomas Brown (Portsmouth)
8.30am - Biomarker vs symptom-driven asthma care: the dangers of over-treatment in multimorbid patients Jodie Lam (London)
9.00am - Feeling good, doing bad: the dangers of under-treatment in ‘well’ patients Dr Sarah Diver (Leicester)
9.30am - 'Quality of life in severe asthma - are we measuring the right thing?' Dr Mathew Masoli (Exeter)
8:30 AM
90 MINUTE SESSION
Learning outcomes
To understand the latest insights into the relationship between airway nerve function and inflammation in the asthmatic airway.
To understand the role of subclinical inflammation and lung function decline in asthma.
To understand the role of T2 biomarkers in limiting overuse of asthma therapies and promoting steroid stewardship.
Curriculum mapping
Managing patients in an outpatient clinic, ambulatory or community setting, including management of long-term conditions.
Tertiary subspecialties interface: managing patients across the secondary and tertiary interface.
Managing the use of drugs and therapeutic modalities specific to the practice of respiratory medicine.
Communicates effectively and is able to share decision making, while maintaining appropriate situational awareness, professional behaviour and professional judgement.
Works in partnership with the respiratory multi-disciplinary team (e.g. physiotherapists, specialist nurses, palliative care team, pharmacists, physiologists and psychologists).